Injectable Calcium Hydroxylapatite for Correction of Nasal Bridge Deformities
- First Online:
- Cite this article as:
- Siclovan, H.R. & Jomah, J.A. Aesth Plast Surg (2009) 33: 544. doi:10.1007/s00266-008-9281-0
- 279 Downloads
Minimally invasive procedures for aesthetic surgery have become widely popular, and facial soft tissue augmentation is one of the most common procedures. Various kinds of fillers have been used, and recently the use of calcium hydroxylapatite was extended to cosmetic facial procedures. This article presents the authors’ experience with primary and secondary nasal bridge correction using calcium hydroxylapatite (Radiesse).
This preliminary prospective study investigated the use of commercially available calcium hydroxylapatite (Radiesse) for correction of nasal bridge deformities. Calcium hydroxylapatite was injected on the plane of the periosteum in a retrograde fashion using a linear, threading, fanning, or crosshatching technique. The patients were followed for several months, with the outcome and side effects assessed both subjectively and objectively.
Patients showed a persistence of benefit up to 1 year during the follow-up period, with pleasing long-term results.
Calcium hydroxylapatite (Radiesse) is a useful injectable filler for correction of nasal bridge deformities. Further efficacy studies seem justified.